𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Histone deacetylase 3 as a novel therapeutic target in multiple myeloma

✍ Scribed by Minami, J; Suzuki, R; Mazitschek, R; Gorgun, G; Ghosh, B; Cirstea, D; Hu, Y; Mimura, N; Ohguchi, H; Cottini, F; Jakubikova, J; Munshi, N C; Haggarty, S J; Richardson, P G; Hideshima, T; Anderson, K C

Book ID
120926174
Publisher
Nature Publishing Group
Year
2013
Tongue
English
Weight
1021 KB
Volume
28
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Histone deacetylase as a therapeutic tar
Histone deacetylase as a therapeutic target
✍ Oliver H. KrΓ€mer; Martin GΓΆttlicher; Thorsten Heinzel πŸ“‚ Article πŸ“… 2001 πŸ› Elsevier Science 🌐 English βš– 623 KB
NAD+-dependent histone deacetylases (sir
NAD+-dependent histone deacetylases (sirtuins) as novel therapeutic targets
✍ JΓΆrg Schemies; Urszula Uciechowska; Wolfgang Sippl; Manfred Jung πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 418 KB

Histone deacetylases (HDACs) are enzymes that cleave off acetyl groups from acetyl-lysine residues in histones and various nonhistone proteins. Four different classes of HDACs have been identified in humans so far. Although classes I, II, and IV are zinc-dependent amidohydrolases, class III HDACs de

NF- B as a Therapeutic Target in Multipl
NF- B as a Therapeutic Target in Multiple Myeloma
✍ Hideshima, T.; Chauhan, D.; Richardson, P.; Mitsiades, C.; Mitsiades, N.; Hayash πŸ“‚ Article πŸ“… 2002 πŸ› The American Society for Biochemistry and Molecula 🌐 English βš– 469 KB